Batch evidence

Quality evidence that keeps specification and result separate.

A complete quality review connects molecular identity, analytical method, specification, result, issuer, and batch provenance in one traceable document package.

Request the applicable document index

Specification, method, result, manufacturing site, document status, and target-market suitability are confirmed per product and batch.

Operators working beside liquid chromatography instruments in an instrument room.
Liquid chromatography instruments and operators in the instrument room.

Inside the instrument room

Instruments, samples, and operator handling.

Field photographs connect the liquid chromatography workstation, autosampler, and sample handling. Method suitability and results are reviewed against the applicable sample and analytical records.

Two operators inspecting the autosampler area of a liquid chromatography instrument.
Two operators inspecting the autosampler area of a liquid chromatography instrument.
A gloved hand holding a sample vial near a liquid chromatography autosampler.
A gloved hand holding a sample vial near a liquid chromatography autosampler.
A liquid chromatography instrument with its workstation.
A liquid chromatography instrument with its workstation.
Quality analyst reviewing batch records beside an HPLC chromatogram
Analytical review connects chromatographic data with batch documentation.

CoA and analytical support

Use batch documents for the sourcing decision.

≥99%Portfolio specification by HPLC

The public portfolio specification is ≥99% by product-appropriate HPLC. The applicable sample identity, method, batch result, issuer, and CoA govern every sourcing decision.

  • Original files retain issuer, sample alias, and batch provenance
  • Identity review by LC-MS where applicable
  • Purity review by product-appropriate RP-HPLC or UPLC

Quality review index

Build a complete quality package from traceable records.

The quality route connects product identity, analytical method, specification, result, and source provenance, then organizes the applicable records for technical and procurement review.

  1. 01
    Identity recordLC-MS · ID · Project-specific
    Review focusConfirm molecular identity

    Source file, sample alias, method, and instrument context remain attached to the review.

  2. 02
    Purity recordRP-HPLC / UPLC · Project-specific
    Review focusSeparate specification from result

    Method, wavelength, column, integration, and related-peak context are reviewed together.

  3. 03
    Composition recordApplicable assay · Project-specific
    Review focusCharacterize supplied material

    Water, residual solvents, counter-ion, and peptide content are aligned to the actual material form.

  4. 04
    Batch recordCoA · supporting records · Project-specific
    Review focusConnect evidence to the offer

    Product, batch, responsible site, release status, and disclosure rights govern the document set.

Source document library

Review the original CoA and chromatographic records with their product, lot, method, and report context intact.

Semaglutide CoA: first-page preview of the source document
SemaglutideCoA

Peptide 34 review copy

Lot Kh701 · Reported 20 Apr 2026 · 2 pages

Open original PDF
Semaglutide HPLC: first-page preview of the source document
SemaglutideHPLC

Peptide 34 chromatogram

Main-peak area 99.337% · 210 nm · 1 page

Open original PDF
Tirzepatide HPLC: first-page preview of the source document
TirzepatideHPLC

Peptide 39 chromatogram

Main-peak area 99.309% · 214 nm · 1 page

Open original PDF

Each source record retains its original issuer, sample, method, lot, date, result, laboratory, and operator fields. Main-peak area and peptide content are presented as distinct analytical measures; current supply decisions use the applicable batch CoA.

Document pathway

Move the right documents through each project stage.

Documents are organized by product, batch, manufacturing site, project stage, target market, and confidentiality level, creating a clear path from initial scope to the final decision record.

Batch-document review beside chromatography systems
Batch documentation and analytical evidence reviewed in one workflow.
  1. 01

    Initial scope

    Public identity, portfolio specification, and available document categories.

  2. 02

    Qualification

    Company, intended use, target market, product, batch, and responsible-site review.

  3. 03

    NDA review

    Controlled technical, quality, traceability, and manufacturing information where applicable.

  4. 04

    Decision record

    Approved specification, CoA, method context, packaging, release, and supply records for the proposed offer.

Decision framework

Core quality attributes in sourcing review

Method families connect each quality attribute to the analytical decision it supports; the applicable product specification and batch CoA complete the record.

Quality attributeApplicable method familyDecision supported
IdentityLC-MS or intact mass where applicableConfirm the peptide and modification state
PurityProduct-appropriate RP-HPLC or UPLCReport the main component and related peptides
CompositionWater, counter-ion, residual solvents, peptide contentCharacterize the supplied material
Batch recordSpecification, CoA, methods, and supporting recordsSupport product- and batch-specific review